The detailed information for PTAB case with proceeding number IPR2016-01596 filed by Alembic Pharmaceuticals Limited against UCB Pharma GmbH on Aug 22, 2016. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2016-01596
Filing Date
Aug 22, 2016
Petitioner
Alembic Pharmaceuticals Limited
Respondent
UCB Pharma GmbH
Status
Final Written Decision
Respondent Application Number
10130214
Respondent Tech Center
1600
Respondent Patent Number
6858650
Institution Decision Date
Dec 7, 2016
Termination Date
Jul 19, 2017

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

FINAL WRITTEN DECISION - Finding Claims 1–5 and 21–24 Not Unpatentable - Dismissing as Moot Patent Owner’s Motion to Exclude - Granting Joint Motion to Seal and Entering Default Protective Order

Jul 19, 2017PAPERBOARD

Trial Instituted Document

Dec 7, 2016PAPERBOARD

EXPUNGED

Sep 19, 2016PAPERPETITIONER

Patent Owner Mandatory Notice Information

Sep 9, 2016PAPERPATENT OWNER

Patent Owner Power of Attorney

Sep 9, 2016PAPERPATENT OWNER

Notice of Accord Filing Date

Aug 29, 2016PAPERBOARD

Declaration of Steven E. Patterson. Ph.D.

Aug 22, 2016EXHIBITPETITIONER

C.V. for Steven E. Patterson, Ph.D.

Aug 22, 2016EXHIBITPETITIONER

Johansson WO 9411337

Aug 22, 2016EXHIBITPETITIONER

Brynne 1997

Aug 22, 2016EXHIBITPETITIONER

Thomas British Heart Journal 1995

Aug 22, 2016EXHIBITPETITIONER

U.S.P.N. 6,858,650

Aug 22, 2016EXHIBITPETITIONER

File History for U.S.P.N. 6,858,650 - Part 1

Aug 22, 2016EXHIBITPETITIONER

File History for U.S.P.N. 6,858,650 - Part 2

Aug 22, 2016EXHIBITPETITIONER

File History for U.S.P.N. 6,858,650 - Part 3

Aug 22, 2016EXHIBITPETITIONER

File History for U.S.P.N. 6,858,650 - Part 4

Aug 22, 2016EXHIBITPETITIONER

Andersson Review BJU International 1999

Aug 22, 2016EXHIBITPETITIONER

Detrol Label Pharmacia and Upjohn

Aug 22, 2016EXHIBITPETITIONER

Bundgaard Design of Prodrugs 1985 - Part 1

Aug 22, 2016EXHIBITPETITIONER

Bundgaard Design of Prodrugs 1985 - Part 3

Aug 22, 2016EXHIBITPETITIONER

Bundgaard Design of Prodrugs 1985 - Part 4

Aug 22, 2016EXHIBITPETITIONER

Nilvebrant Pharmacology and Toxicology 1997

Aug 22, 2016EXHIBITPETITIONER

Lipinski - Advanced Drug Delivery Reviews 1997

Aug 22, 2016EXHIBITPETITIONER

AUA Guideline

Aug 22, 2016EXHIBITPETITIONER

PM360 - April 1, 2012 Overactive Bladder Market

Aug 22, 2016EXHIBITPETITIONER

Postlind Drug Metabolism and Disposition 1998

Aug 22, 2016EXHIBITPETITIONER

Brynne 1998

Aug 22, 2016EXHIBITPETITIONER

Bundgaard Design of Prodrugs 1985 - Part 2

Aug 22, 2016EXHIBITPETITIONER

Anderson 1998

Aug 22, 2016EXHIBITPETITIONER

DeMaagd 2012

Aug 22, 2016EXHIBITPETITIONER

Appell - Urology 1997

Aug 22, 2016EXHIBITPETITIONER

Ashworth - Home Care Provider 1997

Aug 22, 2016EXHIBITPETITIONER

Bundgaard - WO 9208459

Aug 22, 2016EXHIBITPETITIONER

Pfizer 2012 Press Release

Aug 22, 2016EXHIBITPETITIONER

Toviaz Label - Pfizer Labs

Aug 22, 2016EXHIBITPETITIONER

FDA Approval Letter - NDA20-771

Aug 22, 2016EXHIBITPETITIONER

FDA Guidance - October 1999

Aug 22, 2016EXHIBITPETITIONER

Alabaster 1997

Aug 22, 2016EXHIBITPETITIONER

Takeuchi 1997

Aug 22, 2016EXHIBITPETITIONER

Begley 1996

Aug 22, 2016EXHIBITPETITIONER

Gould - International Journal of Pharmaceutics 1986

Aug 22, 2016EXHIBITPETITIONER

Goldberg 1997

Aug 22, 2016EXHIBITPETITIONER

Dkt 6 2015-01-28 Summons Returned Executed, Case No. 15-cv-00079

Aug 22, 2016EXHIBITPETITIONER

CV for DeForest McDuff, Ph.D.

Aug 22, 2016EXHIBITPETITIONER

U.S. OAB Prescriptions and Shares by Drug 2008-2014

Aug 22, 2016EXHIBITPETITIONER

U.S. OAB Sales and Shares by Drug 2008-2014

Aug 22, 2016EXHIBITPETITIONER

Prescription Path of Toviaz and Other OABs

Aug 22, 2016EXHIBITPETITIONER

Sales Path of Toviaz Compound to Pharmaceutical Industry Benchmark

Aug 22, 2016EXHIBITPETITIONER

Comparison of Toviaz Sales to Compound to Pharmaceutical Ind. Benchmarks

Aug 22, 2016EXHIBITPETITIONER

Chart of Sales Path of Toviaz

Aug 22, 2016EXHIBITPETITIONER

Estimates of Expected RandD Costs

Aug 22, 2016EXHIBITPETITIONER

Declaration of DeForest McDuff, Ph.D.

Aug 22, 2016EXHIBITPETITIONER

Toviaz - Don't Let Overactive Bladder Stop You In Your Tracks

Aug 22, 2016EXHIBITPETITIONER

Toviaz U.S. and Worldwide Sales

Aug 22, 2016EXHIBITPETITIONER

U.S. OAB Market Share Prescriptions and Sales by Drug 2000-2007

Aug 22, 2016EXHIBITPETITIONER

Sales Path of Toviaz and Other OABs

Aug 22, 2016EXHIBITPETITIONER

Present Value of Toviaz U.S. Sales

Aug 22, 2016EXHIBITPETITIONER

Present Value of Toviaz Worldwide Sales

Aug 22, 2016EXHIBITPETITIONER

U.S. OAB Detail Shares by Drug 2008-2015

Aug 22, 2016EXHIBITPETITIONER

Consumer Price Index

Aug 22, 2016EXHIBITPETITIONER

Berge 1977

Aug 22, 2016EXHIBITPETITIONER

Petition

Aug 22, 2016PAPERPETITIONER

Power of Attorney

Aug 22, 2016PAPERPETITIONER

Motion for Joinder

Aug 22, 2016PAPERPETITIONER